128 related articles for article (PubMed ID: 24457161)
1. IGFBP-3 promoter polymorphism -202A>C (rs2854774) contributes to prostate cancer risk: evidence based on 9,482 subjects.
Ding Q; Shi Y; Fan B; Fan Z; Wang J
Urol Int; 2014; 93(1):100-7. PubMed ID: 24457161
[TBL] [Abstract][Full Text] [Related]
2. IGF1(CA)19 and IGFBP-3-202A/C gene polymorphism and cancer risk: a meta-analysis.
Quan H; Tang H; Fang L; Bi J; Liu Y; Li H
Cell Biochem Biophys; 2014 May; 69(1):169-78. PubMed ID: 24310658
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms in IGF-I and IGFBP-3 are associated with prostate cancer in the Chinese population.
Qian J; Zhou H; Chen J; Ding Q; Cao Q; Qin C; Shao P; Li P; Cai H; Meng X; Ju X; Wang M; Zhang Z; Li J; Hua L; Yin C
PLoS One; 2014; 9(2):e85609. PubMed ID: 24586243
[TBL] [Abstract][Full Text] [Related]
4. Relationship of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) gene polymorphism with the susceptibility to development of prostate cancer and influence on serum levels of IGF-I, and IGFBP-3.
Safarinejad MR; Shafiei N; Safarinejad S
Growth Horm IGF Res; 2011 Jun; 21(3):146-54. PubMed ID: 21536469
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism in IGFBP3 gene is associated with prostate cancer risk: an updated meta-analysis.
Qie Y; Nian X; Liu X; Hu H; Zhang C; Xie L; Han R; Wu C; Xu Y
Onco Targets Ther; 2016; 9():4163-71. PubMed ID: 27462171
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-binding protein-3 gene -202 A/C polymorphism is correlated with advanced disease status in prostate cancer.
Wang L; Habuchi T; Tsuchiya N; Mitsumori K; Ohyama C; Sato K; Kinoshita H; Kamoto T; Nakamura A; Ogawa O; Kato T
Cancer Res; 2003 Aug; 63(15):4407-11. PubMed ID: 12907612
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians.
Schumacher FR; Cheng I; Freedman ML; Mucci L; Allen NE; Pollak MN; Hayes RB; Stram DO; Canzian F; Henderson BE; Hunter DJ; Virtamo J; Manjer J; Gaziano JM; Kolonel LN; Tjønneland A; Albanes D; Calle EE; Giovannucci E; Crawford ED; Haiman CA; Kraft P; Willett WC; Thun MJ; Le Marchand L; Kaaks R; Feigelson HS; Bueno-de-Mesquita HB; Palli D; Riboli E; Lund E; Amiano P; Andriole G; Dunning AM; Trichopoulos D; Stampfer MJ; Key TJ; Ma J
Hum Mol Genet; 2010 Aug; 19(15):3089-101. PubMed ID: 20484221
[TBL] [Abstract][Full Text] [Related]
8. Association between three genetic variants in kallikrein 3 and prostate cancer risk.
Ding WH; Ren KW; Yue C; Zou JG; Zuo L; Zhang LF; Bai Y; Okada A; Yasui T; Mi YY
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30413614
[TBL] [Abstract][Full Text] [Related]
9. Lack of association of IGFBP-3 gene polymorphisms with colorectal cancer: evidence from 17,380 subjects.
Ge W; Li Y; Xiang H; Li H
Mol Biol Rep; 2014; 41(4):2609-15. PubMed ID: 24464126
[TBL] [Abstract][Full Text] [Related]
10. IGF-1 and IGFBP-3 gene variants influence on serum levels and prostate cancer risk in African-Americans.
Hernandez W; Grenade C; Santos ER; Bonilla C; Ahaghotu C; Kittles RA
Carcinogenesis; 2007 Oct; 28(10):2154-9. PubMed ID: 17724372
[TBL] [Abstract][Full Text] [Related]
11. Association between the 8q24 rs6983267 T/G polymorphism and prostate cancer risk: a meta-analysis.
Zhu HS; Zhang JF; Zhou JD; Zhang MJ; Hu HX
Genet Mol Res; 2015 Dec; 14(4):19329-41. PubMed ID: 26782586
[TBL] [Abstract][Full Text] [Related]
12. Association of Hsa-miR-23a rs3745453 variation with prostate cancer risk among Chinese Han population: A case-control study.
Zhang M; Wang Y; Wang C; You Z; Chen S; Kong Q; Xu B; Liu C; Chen M
Medicine (Baltimore); 2019 Dec; 98(52):e18523. PubMed ID: 31876746
[TBL] [Abstract][Full Text] [Related]
13. The Association Between Three Genetic Variants in MicroRNAs (Rs11614913, Rs2910164, Rs3746444) and Prostate Cancer Risk.
Mi Y; Ren K; Zou J; Bai Y; Zhang L; Zuo L; Okada A; Yasui T
Cell Physiol Biochem; 2018; 48(1):149-157. PubMed ID: 30001553
[TBL] [Abstract][Full Text] [Related]
14. IGF(CA)19 and IGFBP-3-202A/C gene polymorphism in patients with acromegaly.
Akin F; Turgut S; Cirak B; Kursunluoglu R
Growth Horm IGF Res; 2010 Dec; 20(6):399-403. PubMed ID: 20920870
[TBL] [Abstract][Full Text] [Related]
15. IGFBP-3 A-202C and C2133G polymorphisms and colorectal cancer risk: a meta-analysis of case-control studies.
Xu J; Xu L; Li LT; You Q; Cha LS
Genet Mol Res; 2015 Apr; 14(2):3370-86. PubMed ID: 25966104
[TBL] [Abstract][Full Text] [Related]
16. The interleukin-10 promoter polymorphism rs1800872 (-592C>A), contributes to cancer susceptibility: meta-analysis of 16,785 cases and 19,713 controls.
Ding Q; Shi Y; Fan B; Fan Z; Ding L; Li F; Tu W; Jin X; Wang J
PLoS One; 2013; 8(2):e57246. PubMed ID: 23460834
[TBL] [Abstract][Full Text] [Related]
17. Single nucleotide polymorphisms of IGFBP-3 gene and lung cancer risk in a Korean population.
Han SG; Park KH; Sung JS; Whang YM; Kim YJ; Shin ES; Lee JW; Lee HJ; Ryu JS; Choi IK; Seo JH; Kim YH
Lung Cancer; 2008 Nov; 62(2):152-61. PubMed ID: 18450319
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms of xeroderma pigmentosum group D gene Asp312Asn and Lys751Gln and susceptibility to prostate cancer: a systematic review and meta-analysis.
Ma Q; Qi C; Tie C; Guo Z
Gene; 2013 Nov; 530(2):309-14. PubMed ID: 23973729
[TBL] [Abstract][Full Text] [Related]
19. Association between MMP2-1306 C/T polymorphism and prostate cancer susceptibility: a meta-analysis based on 3906 subjects.
Zhang K; Chen X; Zhou J; Yang C; Zhang M; Chao M; Zhang L; Liang C
Oncotarget; 2017 Jul; 8(27):45020-45029. PubMed ID: 28445160
[TBL] [Abstract][Full Text] [Related]
20. Association between IL-18 -607 C/A Polymorphism and the Risk of Prostate Cancer: A Meta-Analysis of Case-Control Studies.
Yuanyuan G; Xue Y; Yachao L; Xiao F; Xu C
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1595-1602. PubMed ID: 31244277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
